DNA repair and survival in lung cancer--the two faces of Janus.
Gazdar
Adi F
AF
Hamon Center for Therapeutic Oncology, University of Texas Southwestern Medical Center, Dallas, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics*; D004260:DNA Repair; D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D004720:Endonucleases / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics*; D017671:Platinum Compounds / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D012262:Ribonucleoside Diphosphate Reductase; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism*
D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; D017671:Platinum Compounds; D025521:Tumor Suppressor Proteins; C475286:RRM1 protein, human; D012262:Ribonucleoside Diphosphate Reductase; C071447:ERCC1 protein, human; D004720:Endonucleases